First-in-human trial of tocilizumab in combination with a standard induction chemotherapy in newly diagnosed acute myeloid leukemia patients: The phase 1 TOCILAM study.

被引：0
|
作者：
Peterlin, Pierre
Garnier, Alice
Le Bourgeois, Amandine
Guillaume, Thierry
Jullien, Maxime
Planche, Lucie
Gaschet, Joelle
Chevallier, Patrice
机构：
[1] CHU Nantes, Serv Hematol Clin, Nantes, France
[2] CHU Nantes, Hotel Dieu HME, Nantes, France
[3] Dept Hosp Ctr, Clin Res Ctr, La Roche Sur Yon, France
[4] Univ Angers, Nantes Univ, CNRS, Inserm,CRCI2NA, Nantes, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7028
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A prospective study of the use of central venous catheters in patients newly diagnosed with acute myeloid leukemia treated with induction chemotherapy
    Christi McKeown
    Asha Ricciuti
    Mounzer Agha
    Anastasios Raptis
    Jing-Zhou Hou
    Rafic Farah
    Robert L. Redner
    Annie Im
    Kathleen A. Dorritie
    Alison Sehgal
    James Rossetti
    Konstantinos Lontos
    Dana H. Bovbjerg
    Daniel Normolle
    Michael Boyiadzis
    Supportive Care in Cancer, 2022, 30 : 1673 - 1679
  • [22] Hematologic Predictors of Outcomes in Patients Undergoing Intensive Induction Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia
    Arain, Saad
    Shah, Eshana
    Yavuz, Betul Gok
    Stettner, Sarah
    Calip, Gregory Sampang
    Khan, Irum
    Patel, Pritesh
    Quigley, John G.
    BLOOD, 2020, 136
  • [23] Effect of Linezolid on Hematologic Recovery in Newly Diagnosed Acute Myeloid Leukemia Patients Following Induction Chemotherapy
    Nedved, Adrienne N.
    DeFrates, Sean R.
    Hladnik, Lindsay M.
    Stockerl-Goldstein, Keith E.
    PHARMACOTHERAPY, 2016, 36 (10): : 1087 - 1094
  • [24] A Phase 1b Study of Vadastuximab Talirine in Combination with 7+3 Induction Therapy for Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)
    Erba, Harry P.
    Levy, Moshe Y.
    Vasu, Sumithira
    Stein, Anthony S.
    Fathi, Amir T.
    Maris, Michael B.
    Advani, Anjali
    Faderl, Stefan
    Smith, Scott E.
    Wood, Brent L.
    Walter, Roland B.
    Yang, Jay
    Donnellan, William B.
    Feldman, Eric J.
    Voellinger, Jenna L.
    Ravandi, Farhad
    BLOOD, 2016, 128 (22)
  • [25] Outcome of Newly Diagnosed Acute Myeloid Leukemia (AML) Refractory to 1 or 2 Cycles of Induction Chemotherapy
    Zarzour, Ahmad
    Nazha, Aziz
    Kalaycio, Matt
    Patel, Bhumika J.
    Gerds, Aaron T.
    Clemente, Michael J.
    Hirsch, Cassandra M.
    Carew, Jennifer S.
    Advani, Anjali S.
    Sanikommu, Srinivasa R.
    Przychodzen, Bartlomiej
    Carraway, Hetty E.
    Mukherjee, Sudipto
    Maciejewski, Jaroslaw P.
    Sekeres, Mikkael A.
    BLOOD, 2015, 126 (23)
  • [26] Phase 1/2 study of tandutinib (MLN518) plus standard induction chemotherapy in newly diagnosed acute myelogenous leukemia (AML).
    DeAngelo, Daniel J.
    Amrein, Philip C.
    Kovacsovics, Tibor J.
    Klisovic, Rebecca B.
    Powell, Bayard L.
    Cooper, Michael
    Webb, Iain J.
    Stone, Richard M.
    BLOOD, 2006, 108 (11) : 51A - 51A
  • [27] Phase 2 Study of Combination of Cytarabine, Idarubicin, and Nivolumab for Initial Therapy of Patients with Newly Diagnosed Acute Myeloid Leukemia
    Ravandi, Farhad
    Daver, Naval
    Garcia-Manero, Guillermo
    Benton, Christopher B.
    Thompson, Philip A.
    Borthakur, Gautam
    Kadia, Tapan
    Boddu, Prajwal C.
    Alvarado, Yesid
    Jabbour, Elias J.
    Konopleva, Marina
    Takahashi, Koichi
    Kornblau, Steven
    DiNardo, Courtney D.
    Estrov, Zeev
    Flores, Wilmer
    Basu, Sreyashi
    Allison, James
    Sharma, Padmanee
    Pierce, Sherry
    Brandt, Mark
    Pike, Allison
    Cortes, Jorge E.
    Kantarjian, Hagop M.
    BLOOD, 2017, 130
  • [28] Sequential Combination of Gemtuzumab Ozogamicin and Standard Chemotherapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia: Results of a Randomized Phase III Trial by the EORTC and GIMEMA Consortium (AML-17)
    Amadori, Sergio
    Suciu, Stefan
    Stasi, Roberto
    Salih, Helmut R.
    Selleslag, Dominik
    Muus, Petra
    De Fabritiis, Paolo
    Venditti, Adriano
    Ho, Anthony D.
    Luebbert, Michael
    Thomas, Xavier
    Latagliata, Roberto
    Halkes, Constantijn J. M.
    Falzetti, Franca
    Magro, Domenico
    Guimaraes, Jose E.
    Berneman, Zwi
    Specchia, Giorgina
    Karrasch, Matthias
    Fazi, Paola
    Vignetti, Marco
    Willemze, Roel
    de Witte, Theo
    Marie, Jean-Pierre
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (35) : 4424 - +
  • [29] Incidence of CDI and Association with Antibiotics in a Cohort of Patients with Newly Diagnosed Acute Myeloid Leukemia Receiving Induction Chemotherapy
    Jakob, Carolin
    Bauquet, Aurelie
    Buffet, Renaud
    Vehreschild, Maria
    Vehreschild, Janne
    BLOOD, 2020, 136
  • [30] A Phase 1 Study of Gilteritinib in Combination with Induction and Consolidation Chemotherapy in Patients with Newly Diagnosed AML: Final Results
    Pratz, Keith W.
    Cherry, Mohamad
    Altman, Jessica K.
    Cooper, Brenda W.
    Cruz, Jose Carlos
    Jurcic, Joseph G.
    Levis, Mark
    Lin, Tara
    Perl, Alexander E.
    Podoltsev, Nikolai A.
    Schiller, Gary J.
    Hill, Jason E.
    James, Angela
    Lu, Qiaoyang
    Tiu, Ramon V.
    BLOOD, 2020, 136
12345